Frick, Elisabet A.
Emilsson, Valur http://orcid.org/0000-0001-9982-0524
Jonmundsson, Thorarinn http://orcid.org/0000-0001-9158-0087
Steindorsdottir, Anna E. http://orcid.org/0000-0002-2386-5934
Johnson, Erik C. B. http://orcid.org/0000-0002-0604-2944
Puerta, Raquel http://orcid.org/0000-0002-1191-5893
Dammer, Eric B. http://orcid.org/0000-0003-2947-7606
Shantaraman, Anantharaman http://orcid.org/0000-0003-1384-941X
Cano, Amanda
Boada, Mercè http://orcid.org/0000-0003-2617-3009
Valero, Sergi
García-González, Pablo http://orcid.org/0000-0003-0125-5403
Gudmundsson, Elias F. http://orcid.org/0000-0002-7661-4872
Gudjonsson, Alexander
Pitts, Rebecca http://orcid.org/0000-0003-4733-414X
Qiu, Xiazi http://orcid.org/0000-0002-8397-2168
Finkel, Nancy
Loureiro, Joseph J. http://orcid.org/0000-0001-7222-9160
Orth, Anthony P. http://orcid.org/0009-0005-9865-0494
Seyfried, Nicholas T. http://orcid.org/0000-0002-4507-624X
Levey, Allan I. http://orcid.org/0000-0002-3153-502X
Ruiz, Agustin http://orcid.org/0000-0003-2633-2495
Aspelund, Thor http://orcid.org/0000-0002-7998-5433
Jennings, Lori L. http://orcid.org/0000-0001-5130-8417
Launer, Lenore J. http://orcid.org/0000-0002-3238-7612
Gudmundsdottir, Valborg http://orcid.org/0000-0002-7459-1603
Gudnason, Vilmundur http://orcid.org/0000-0001-5696-0084
Funding for this research was provided by:
Icelandic Centre for Research (206692-051)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (1K08AG068604, U01AG061357, N01-AG-12100, HHSN271201200022C, 1R01AG065596)
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Sara Borrell (CD22/00125))
Innovative Medicines Initiative (115975, 115985)
Agentschap Innoveren en Ondernemen (Nº PR067/21)
Article History
Received: 11 December 2023
Accepted: 22 July 2024
First Online: 21 August 2024
Change Date: 16 September 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s43587-024-00718-9
Competing interests
: R.P., X.Q., N.F., L.L.J., A.P.O. and J.J.L. are employees and stockholders of Novartis. N.T.S. and A.I.L. are co-founders of Emtherapro. No other potential conflicts of interest relevant to this article were reported.